The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 19, 2022

Filed:

Sep. 15, 2015
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Yi Zhang, Newton, MA (US);

Shogo Matoba, Brookline, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/877 (2010.01); A01K 67/027 (2006.01); C12N 15/113 (2010.01); C12N 5/073 (2010.01); C12N 5/0735 (2010.01);
U.S. Cl.
CPC ...
C12N 15/877 (2013.01); A01K 67/0273 (2013.01); C12N 5/0604 (2013.01); C12N 5/0606 (2013.01); C12N 15/1137 (2013.01); C12Y 201/01043 (2013.01); A01K 2227/105 (2013.01); C12N 2310/14 (2013.01); C12N 2517/04 (2013.01);
Abstract

The present invention provides methods and compostions to improve the efficiency of somatic cell nuclear transfer (SCNT) and the consequent production of nuclear transfer ESC (ntESC) and transgenic cells and/or non-human animals. More specifically, the present invention relates to the discovery that trimethylation of Histone H3-Lysine 9 (H3K9me3) in reprogramming resistant regions (RRRs) in the nuclear genetic material of donor somatic cells prevents efficient somatic cell nuclear reprogramming or SCNT. The present invention provide methods and compositions to decrease H3K9me3 in methods to improve efficacy of SCNT by exogenous or overexpression of the demethylase Kdm4 family and/or inhibiting methylation of H3K9me3 by inhibiting the histone methyltransferases Suv39h1 and/or Suv39h2.


Find Patent Forward Citations

Loading…